Tripledot CEO Calls Deal to Buy Applovin ‘Transformational'
Mobile game developer Tripledot Studios has bought AppLovin's games portfolio for about $800 million. The deal means London-based Tripledot - the company behind popular games including Woodoku and Solitaire - will take control of another 10 studios across key markets in the US and Asia. Co-founder and CEO of Tripledot Studios, Lior Shiff spoke to Bloomberg's Tom Mackenize on "Daybreak Europe." (Source: Bloomberg)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
23 minutes ago
- Bloomberg
Bloomberg: The Asia Trade 9/6/25
"Bloomberg: The Asia Trade" brings you everything you need to know to get ahead as the trading day begins in Asia. Bloomberg TV is live from Tokyo and Sydney with Shery Ahn and Haidi Stroud-Watts, getting insight and analysis from newsmakers and industry leaders on the biggest stories shaping global markets. Note: US Defense Secretary Pete Hegseth said in a post on X that Marines could be sent next if protests intensify in California. (Source: Bloomberg)
Medscape
35 minutes ago
- Medscape
AI Scribes Cutting GPs' Admin and Boosting Patient Care
Artificial intelligence (AI) scribing tools are increasingly being used in NHS settings to enhance patient care and free up staff time. In April, the Department of Health and Social Care announced support for NHS doctors to adopt AI tools that 'bulldoze bureaucracy,' allowing clinicians to focus more on their patients and less on documentation. This follows a multi-site evaluation led by Great Ormond Street Hospital for Children, London, England, and funded by NHS England. The trial tested ambient voice technologies (AVTs) that listen to and transcribe consultations in real time. More than 7000 patients took part across settings including accident and emergency, primary care, community services, and mental health. Interim data from the trial showed increased productivity and more time spent on direct care, particularly in emergency settings. Current AI Scribing Tools in Use Several AI scribing tools are already being used within the NHS. Health technology company Accurx recently teamed up with Tandem Health to launch Accurx Scribe, a tool that can transcribe, summarise, and code patient consultations into a trust's clinical records, with functionality to write back to EMIS and SystmOne. It is currently being rolled out across GP practices using Accurx. At the Royal Wolverhampton NHS Trust, a pilot of CLEARNotes is underway. The tool listens to patient consultations and generates a structured summary of the discussion. Meanwhile, Heidi Health is being used by about 40% of GPs and is being piloted in 15 NHS trusts. The AVT tool provides real-time transcription, without storing audio files, in order to address patients' privacy concerns. GP Practices See Significant Benefits At Modality, a group of general practices in West Yorkshire, Heidi has been installed for all GPs and advanced clinical practitioners. Tom Ratcliffe, a GP partner and digital transformation clinical lead for the group, said: 'Clinicians find that it saves time and reduces their administrative burden, particularly around generating clinical correspondence after consultations.' Tom Ratcliffe Ratcliffe described using an AI scribing tool as 'quite transformative' and particularly beneficial for clinicians who are slower typists or who take longer to write detailed notes. 'One of the really significant benefits we've experienced is that by having an ambient scribe writing the notes while you're speaking with a patient, it enables you to focus more on them,' he told Medscape News UK . 'That's really important, as you're then picking up on non-verbal cues that you can easily miss when you're distracted by the computer.' With GPs having between 30 and 50 clinical contacts per day, 'having to think about exactly what to write for each of those encounters is quite a drain on your mental capacity,' Ratcliffe said. 'My colleagues and I have all found using an ambient scribe helps to reduce your cognitive load. Having a consistent format for the notes for every encounter is also helpful,' he added. Patient Consent and Data Security Educating patients about the software is an important consideration. Thomas Kelly, co-founder and chief executive of Heidi Health, said clinicians are advised to obtain consent before using the tool and to explain to patients how an AI scribe works and what they can expect during a consultation. Thomas Kelly 'Patients can also learn more through a range of resources that GPs can put up in their practices that explain how Heidi works,' Kelly said. A transcription of the consultation will be generated, 'but the audio is not permanently recorded or stored in a way that could ever be breached,' he explained. 'It's just being turned into that documentation in real time, and this process is happening on Heidi's servers in the UK.' However, when a session is deleted from Heidi's servers, 'it's deleted for everyone, and there is no way it can be retrieved.' Ratcliffe said that patients have reacted positively to their Modality GP using an AI scribing tool. 'With all the digital innovations we've introduced, we've always had patients who raised very reasonable questions about the privacy of their data,' he said. 'But the level of patient acceptance of using Heidi has been incredibly high.' Each patient is asked to give their consent for the scribing tool to be used. 'I haven't heard of a single example of a patient declining use in an encounter, and we've done probably hundreds or thousands of these now,' said Ratcliffe. Accuracy Concerns Addressed Andrew Noble works within the frailty service at Jean Bishop Integrated Care Centre in East Hull, England. He uses Heidi for consultations lasting up to an hour, which require lengthy administration time. Andrew Noble Staff training on the system emphasises vigilance about possible AI hallucinations in output. According to Noble, one or two minor errors might occur during an hour-long consultation transcription. However, for shorter appointments, lasting 15 minutes, clinicians might expect error-free note-taking from the AI scribe. Use of the tool has significantly improved the quality of note-taking. 'The Heidi AI scribe halved the number of spelling mistakes, and it reduced the number of abbreviations quite significantly as well,' said Noble. Mistakes might include US spellings of antibiotics or the scribe mishearing the name of a medication. 'But we do have human error when inputting our own notes, so those things were already happening from time to time,' Noble observed. Ratcliffe tested multiple AI scribe options before selecting Heidi Health. All platforms occasionally made minor errors. 'Anyone who uses any form of generative AI does find it will occasionally confabulate or hallucinate,' he said. 'One of the key parts of our training was around educating clinicians on the importance of understanding that their role has gone from spending lots of time typing up notes to carefully reading a transcript and checking for any potential issues.' Overall, 'we haven't found that the error rate is high enough that means it's unsafe or not practical to use,' said Ratcliffe. Game-Changing Technology? Health Secretary Wes Streeting has described AI as a catalyst that will revolutionise healthcare. GPs appear to share this optimism. 'This was something that we worked really hard to roll out quickly because we did feel that it was game-changing,' Ratcliffe explained. 'I think it has been game-changing for a lot of our clinicians. When used properly, it can make a big difference.' With GPs working 'above and beyond,' Ratcliffe believes that AI scribing tools 'could help us to move back to a safer place in terms of making our workload more manageable.'
Yahoo
43 minutes ago
- Yahoo
Getty's landmark UK lawsuit on copyright and AI set to begin
By Sam Tobin LONDON (Reuters) -Getty Images' landmark copyright lawsuit against artificial intelligence company Stability AI begins at London's High Court on Monday, with the photo provider's case likely to set a key precedent for the law on AI. The Seattle-based company, which produces editorial content and creative stock images and video, accuses Stability AI of breaching its copyright by using its images to "train" its Stable Diffusion system, which can generate images from text inputs. Getty, which is bringing a parallel lawsuit against Stability AI in the United States, says Stability AI unlawfully scraped millions of images from its websites and used them to train and develop Stable Diffusion. Stability AI – which has raised hundreds of millions of dollars in funding and in March announced investment by the world's largest advertising company, WPP – is fighting the case and denies infringing any of Getty's rights. A Stability AI spokesperson said that "the wider dispute is about technological innovation and freedom of ideas," adding: "Artists using our tools are producing works built upon collective human knowledge, which is at the core of fair use and freedom of expression." Getty's case is one of several lawsuits brought in Britain, the U.S. and elsewhere over the use of copyright-protected material to train AI models, after ChatGPT and other AI tools became widely available more than two years ago. WIDER IMPACT Creative industries are grappling with the legal and ethical implications of AI models that can produce their own work after being trained on existing material. Prominent figures including Elton John have called for greater protections for artists. Lawyers say Getty's case will have a major impact on the law, as well as potentially informing government policy on copyright protections relating to AI. "Legally, we're in uncharted territory. This case will be pivotal in setting the boundaries of the monopoly granted by UK copyright in the age of AI," Rebecca Newman, a lawyer at Addleshaw Goddard, who is not involved in the case, said. She added that a victory for Getty could mean that Stability AI and other developers will face further lawsuits. Cerys Wyn Davies, from the law firm Pinsent Masons, said the High Court's ruling "could have a major bearing on market practice and the UK's attractiveness as a jurisdiction for AI development".
